Arbyn, Marc.
Marc Arbyn researcher (ORCID 0000-0001-8434-8263)
Arbyn, M.
Arbyn, M. (Marc)
VIAF ID: 23352190 (Personal)
Permalink: http://viaf.org/viaf/23352190
Preferred Forms
-
- 100 1 _ ‡a Arbyn, M.
- 100 1 _ ‡a Arbyn, M. ‡q (Marc)
-
-
- 100 1 _ ‡a Arbyn, Marc
-
- 100 1 _ ‡a Arbyn, Marc
-
- 100 0 _ ‡a Marc Arbyn ‡c researcher (ORCID 0000-0001-8434-8263)
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis | |
ANOVA model for network meta-analysis of diagnostic test accuracy data | |
Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006). | |
Barriers and opportunities for return-to-work of cancer survivors: time for action--rapid review and expert consultation | |
Belgian Parliament calls for organised cervical cancer screening and HPV research throughout Europe | |
The burden of cervical cancer in South-East Europe at the beginning of the 21st century | |
Changes in type-specific human papillomavirus load predict progression to cervical cancer | |
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses | |
Comprehensive control of human papillomavirus infections and related diseases | |
Detection of false negative Pap smears by rapid reviewing. A metaanalysis | |
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease | |
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice | |
European guidelines for quality assurance in cervical cancer screening | |
The European response to the WHO call to eliminate cervical cancer as a public health problem | |
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer | |
The future role for colposcopy in Europe. | |
Geographic and temporal variations in the incidence of vulvar and vaginal cancers | |
High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006). | |
Highlights of the 26th international papillomavirus conference and workshops. | |
HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy | |
HPV testing versus cervical cytology for screening for cancer of the uterine cervix | |
Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis | |
Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV | |
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test. | |
Impact of genetic notification on smoking cessation: systematic review and pooled-analysis | |
Increased risk of preterm birth after treatment for CIN | |
Long term outcomes for women treated for cervical precancer | |
Low cost versus other screening tests to detect cervical cancer or precancer in developing countries | |
Management of low-grade squamous intra-epithelial lesions of the uterine cervix: repeat cytology versus immediate referral to colposcopy | |
Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears. | |
Metaprop: a Stata command to perform meta-analysis of binomial data | |
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities | |
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis | |
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis | |
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis | |
Prevention of cervical cancer : guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on triage, treatment and follow-up = Prävention des Zervixkarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Register-Nummer 015/027OL, Dezember 2017) - Teil 2 mit Abklärung, Therapie und Nachbetreuung | |
Prevention of human papillomavirus-related malignancies of the female genital tract | |
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model | |
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors | |
Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia | |
Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection? | |
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. | |
Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP | |
The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. | |
Trends of cervical cancer mortality in the member states of the European Union | |
Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer | |
Triage of HPV positive women in cervical cancer screening | |
Triage with human papillomavirus (HPV) testing versus repeat cytology for underlying high-grade cervical intra-epithelial neoplasia in women with minor cytological lesions | |
The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach | |
The use of human tissue in epidemiological research; ethical and legal considerations in two biobanks in Belgium | |
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia | |
Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis | |
What's next? : perspectives and future needs of cervical csreening in Europe in the era of molecular testing and vaccination |